Junxia Yao
Overview
Explore the profile of Junxia Yao including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
38
Citations
282
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Xi D, Xu M, Han M, Guan Q, Guo Q, Yan F, et al.
J Hepatocell Carcinoma
. 2023 Jun;
10:909-920.
PMID: 37346771
Purpose: A retrospective analysis of hepatocellular carcinoma (HCC) patients treated with transarterial chemoembolization (TACE) to identify risk factors was conducted, and a novel predictive nomogram model was constructed. Patients And...
2.
Ye J, Yao J, He F, Sun J, Zhao Z, Wang Y
Front Cell Infect Microbiol
. 2023 Jun;
13:1169500.
PMID: 37346031
Kidney transplantation is an effective method to improve the condition of patients with end-stage renal disease. The gut microbiota significantly affects the immune system and can be used as an...
3.
Cheng M, Jing H, Bu D, Liu J, Lu K, Liu J, et al.
BMC Gastroenterol
. 2023 Jun;
23(1):194.
PMID: 37277702
Background: Although schistosomiasis has been basically eliminated, it has not been completely extinction in China and occasional outbreaks occur in Europe in recent years. The relationship between inflammation caused by...
4.
Wang W, Zhang Y, Liu J, Jing H, Lu K, Wang L, et al.
World J Surg Oncol
. 2023 Feb;
21(1):31.
PMID: 36726115
Aim: To compare the prognostic value of tumor-infiltrating lymphocytes (TILs) and CD3 + cells and CD20 + cells between schistosomal colorectal cancer (SCRC) and non-schistosomal CRC (NSCRC). Background: Although schistosomiasis...
5.
Wei L, Wang W, Yao J, Cui Z, Xu Z, Ding H, et al.
Oncogene
. 2022 Aug;
41(37):4282-4294.
PMID: 35974143
Most basal-like breast cancers (BLBCs) are triple-negative breast cancers (TNBCs), which is associated with high malignancy, high rate of recurrence and distant metastasis, and poor prognosis among all types of...
6.
Lu C, Hu D, Zheng J, Cao S, Zhu J, Chen X, et al.
Biomed Res Int
. 2022 May;
2022:4010786.
PMID: 35528167
Tumor microenvironment (TME) has been revealed as an important determinant of diagnosis and treatment response in AML patients. The scores of immune and stromal cell scores of AML in the...
7.
Liu J, Yao J, Zhao Y, Su J, Ye J, Wang Y
J Transl Med
. 2022 Apr;
20(1):185.
PMID: 35468852
Background: Microlbuminuria is the earliest clinical evidence of diabetic kidney disease (DKD) and contributes to the induction and/or progression of DKD. Previous studies have shown that increased expression of angiopoietin2...
8.
Liu Y, Ma L, Hua F, Min Z, Zhan Y, Zhang W, et al.
Oncogene
. 2022 Feb;
41(14):2137.
PMID: 35194153
No abstract available.
9.
Liu Y, Ma L, Hua F, Min Z, Zhan Y, Zhang W, et al.
Oncogene
. 2022 Jan;
41(14):2012-2025.
PMID: 35027669
Cancer stem cells (CSC) are the major obstacle for cancer therapy in clinic. Exosomes are one type of vesicles that containing circular RNA (circRNAs) involved in cell-cell communication. However, the...
10.
Wang W, Jing H, Liu J, Bu D, Zhang Y, Zhu T, et al.
World J Surg Oncol
. 2021 Nov;
19(1):321.
PMID: 34743724
Background: The effect of schistosomiasis on CD8+ T cells and then on PD-L1 expression was unknown, and the utility of CD8+ TILs as a biomarker for schistosomal-associated colorectal cancer (SCRC)...